Rapamune and Decadron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Rapamune (sirolimus) and Decadron (dexamethasone). Common drug interactions include hyponatraemia among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Rapamune and Decadron. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Rapamune?

Rapamune has active ingredients of sirolimus. It is often used in kidney transplant. eHealthMe is studying from 13,848 Rapamune users. Check the latest studies of Rapamune.

What is Decadron?

Decadron has active ingredients of dexamethasone. It is often used in multiple myeloma. eHealthMe is studying from 47,210 Decadron users. Check the latest studies of Decadron.

On Jul, 11, 2026

44 people who take Rapamune and Decadron together, and have interactions are studied.

Rapamune and Decadron drug interactions.

What are the common drug interactions of Rapamune and Decadron, by gender? *:

female:

Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Leukopenia (less number of white blood cells in blood)
Vomiting
Epistaxis (bleed from the nose)
Mouth ulceration (mouth ulcers)
Rash
Somnolence (a state of near-sleep, a strong desire for sleep)
Anaemia (lack of blood)
Disease progression
Hypokalaemia (low potassium)

male:

Asthenia (weakness)
Dyspnoea (difficult or laboured respiration)
Discomfort
Dysphagia (a condition in which swallowing is difficult or painful)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Hypertension (high blood pressure)
Incontinence (lack of moderation or self-control)
Joint swelling

What are the common drug interactions of Rapamune and Decadron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Asthenia (weakness)
Blood pressure increased
Cough
Death
Discomfort
Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
Fatigue (feeling of tiredness)
Headache (pain in head)

50-59:

Dehydration (dryness resulting from the removal of water)
Depressed level of consciousness
Diarrhoea
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Lethargy (tiredness)
Leukopenia (less number of white blood cells in blood)
Mucosal inflammation (infection of mucous membrane)
Pneumonia
Activities of daily living impaired
Aphagia (inability or refusal to swallow)

60+:

Asthenia (weakness)
Osteonecrosis (death of bone)
Renal failure (kidney dysfunction)
Atelectasis (partial or complete collapse of the lung)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Coma (state of unconsciousness lasting more than six hours)
Drug intolerance (drug sensitivity)
Drug toxicity
Electrolyte imbalance
Encephalitis (inflammation of the brain)

What are the existing conditions these people have? *

Glioblastoma Multiforme (most common and deadliest of malignant primary brain tumours in adults): 23 people, 52.27%

* Approximation only. Some reports may have incomplete information.

Do you take Rapamune and Decadron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously